{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T10:15:00Z","timestamp":1789467300992,"version":"build-2803163510"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2008,4,2]],"date-time":"2008-04-02T00:00:00Z","timestamp":1207094400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Causes Control"],"published-print":{"date-parts":[[2008,10]]},"DOI":"10.1007\/s10552-008-9151-8","type":"journal-article","created":{"date-parts":[[2008,4,1]],"date-time":"2008-04-01T08:02:17Z","timestamp":1207036937000},"page":"887-894","source":"Crossref","is-referenced-by-count":97,"title":["Cancer risk in a cohort of patients with systemic lupus erythematosus (SLE) in California"],"prefix":"10.1007","volume":"19","author":[{"given":"Arti","family":"Parikh-Patel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard H.","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Allen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosemary","family":"Cress","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,4,2]]},"reference":[{"key":"9151_CR1","doi-asserted-by":"crossref","unstructured":"Abu-Shakra M, Buskila D, Shoenfeld Y (2000) SLE and cancer. In: Shoenfeld Y, Gershwin ME (eds) Cancer and autoimmunity. Elsevier Science, pp 31\u201340","DOI":"10.1016\/B978-044450331-2\/50004-7"},{"key":"9151_CR2","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.autrev.2004.07.003","volume":"3","author":"M Abu-Shakra","year":"2004","unstructured":"Abu-Shakra M, Gladman DD, Urowitz MB (2004) Mortality studies in SLE: how far can we improve survival of patients with SLE. Autoimmun Rev 3:418\u2013420","journal-title":"Autoimmun Rev"},{"key":"9151_CR3","first-page":"685","volume":"27","author":"C Stahl-Hallengren","year":"2000","unstructured":"Stahl-Hallengren C, Jonsen A, Nived O, Sturfelt G (2000) Incidence studies of systemic lupus erythematosus in Southern Sweden: increasing age, decreasing frequency of renal manifestations and good prognosis. J Rheumatol 27:685\u2013691","journal-title":"J Rheumatol"},{"key":"9151_CR4","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1093\/rheumatology\/39.3.238","volume":"39","author":"MB Urowitz","year":"2000","unstructured":"Urowitz MB, Gladman DD (2000) How to improve morbidity and mortality in systemic lupus erythematosus. Rheumatology (Oxford) 39:238\u2013244","journal-title":"Rheumatology (Oxford)"},{"key":"9151_CR5","first-page":"1061","volume":"24","author":"MB Urowitz","year":"1997","unstructured":"Urowitz MB, Gladman DD, Abu-Shakra M, Farewell VT (1997) Mortality studies in systemic lupus erythematosus. Results from a single center. III. Improved survival over 24\u00a0years. J Rheumatol 24:1061\u20131065","journal-title":"J Rheumatol"},{"key":"9151_CR6","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1002\/art.21029","volume":"52","author":"S Bernatsky","year":"2005","unstructured":"Bernatsky S, Boivin JF, Joseph L et\u00a0al (2005) An international cohort study of cancer in systemic lupus erythematosus. Arthritis Rheum 52:1481\u20131490","journal-title":"Arthritis Rheum"},{"key":"9151_CR7","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1136\/ard.2004.034504","volume":"64","author":"S Bernatsky","year":"2005","unstructured":"Bernatsky S, Ramsey-Goldman R, Rajan R et\u00a0al (2005) Non-Hodgkin\u2019s lymphoma in systemic lupus erythematosus. Ann Rheum Dis 64:1507\u20131509","journal-title":"Ann Rheum Dis"},{"key":"9151_CR8","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1080\/03009740252937568","volume":"31","author":"L Bjornadal","year":"2002","unstructured":"Bjornadal L, Lofstrom B, Yin L, Lundberg IE, Ekbom A (2002) Increased cancer incidence in a Swedish cohort of patients with systemic lupus erythematosus. Scand J Rheumatol 31:66\u201371","journal-title":"Scand J Rheumatol"},{"key":"9151_CR9","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1002\/art.1780400424","volume":"40","author":"L Mellemkjaer","year":"1997","unstructured":"Mellemkjaer L, Andersen V, Linet MS, Gridley G, Hoover R, Olsen JH (1997) Non-Hodgkin\u2019s lymphoma and other cancers among a cohort of patients with systemic lupus erythematosus. Arthritis Rheum 40:761\u2013768","journal-title":"Arthritis Rheum"},{"key":"9151_CR10","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1136\/ard.51.4.437","volume":"51","author":"T Pettersson","year":"1992","unstructured":"Pettersson T, Pukkala E, Teppo L, Friman C (1992) Increased risk of cancer in patients with systemic lupus erythematosus. Ann Rheum Dis 51:437\u2013439","journal-title":"Ann Rheum Dis"},{"key":"9151_CR11","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1191\/0961203303lu443oa","volume":"12","author":"O Ragnarsson","year":"2003","unstructured":"Ragnarsson O, Grondal G, Steinsson K (2003) Risk of malignancy in an unselected cohort of Icelandic patients with systemic lupus erythematosus. Lupus 12:687\u2013691","journal-title":"Lupus"},{"key":"9151_CR12","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1191\/096120301701548481","volume":"10","author":"Y Xu","year":"2001","unstructured":"Xu Y, Wiernik PH (2001) Systemic lupus erythematosus and B-cell hematologic neoplasm. Lupus 10:841\u2013850","journal-title":"Lupus"},{"key":"9151_CR13","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1001\/archinte.165.20.2337","volume":"165","author":"E Zintzaras","year":"2005","unstructured":"Zintzaras E, Voulgarelis M, Moutsopoulos HM (2005) The risk of lymphoma development in autoimmune diseases: a meta-analysis. Arch Intern Med 165:2337\u20132344","journal-title":"Arch Intern Med"},{"key":"9151_CR14","first-page":"217","volume":"46","author":"R Ramsey-Goldman","year":"1998","unstructured":"Ramsey-Goldman R, Mattai SA, Schilling E et\u00a0al (1998) Increased risk of malignancy in patients with systemic lupus erythematosus. J Investig Med 46:217\u2013222","journal-title":"J Investig Med"},{"key":"9151_CR15","first-page":"1478","volume":"22","author":"DM Sweeney","year":"1995","unstructured":"Sweeney DM, Manzi S, Janosky J et\u00a0al (1995) Risk of malignancy in women with systemic lupus erythematosus. J Rheumatol 22:1478\u20131482","journal-title":"J Rheumatol"},{"issue":"Suppl A","key":"9151_CR16","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/0896-8411(92)90055-U","volume":"5","author":"LJ Kinlen","year":"1992","unstructured":"Kinlen LJ (1992) Malignancy in autoimmune diseases. J Autoimmun 5 (Suppl A):363\u2013371","journal-title":"J Autoimmun"},{"key":"9151_CR17","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s11926-002-0045-6","volume":"4","author":"S Bernatsky","year":"2002","unstructured":"Bernatsky S, Clarke A, Ramsey-Goldman R (2002) Malignancy and systemic lupus erythematosus. Curr Rheumatol Rep 4:351\u2013358","journal-title":"Curr Rheumatol Rep"},{"key":"9151_CR18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-3-642-56352-2_1","volume":"159","author":"SH Oertel","year":"2002","unstructured":"Oertel SH, Riess H (2002) Immunosurveillance, immunodeficiency and lymphoproliferations. Recent Results Cancer Res 159:1\u20138","journal-title":"Recent Results Cancer Res"},{"key":"9151_CR19","first-page":"1316","volume":"20","author":"R Bhalla","year":"1993","unstructured":"Bhalla R, Ajmani HS, Kim WW, Swedler WI, Lazarevic MB, Skosey JL (1993) Systemic lupus erythematosus and Hodgkin\u2019s lymphoma. J Rheumatol 20:1316\u20131320","journal-title":"J Rheumatol"},{"key":"9151_CR20","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1002\/art.1780250916","volume":"25","author":"KA Black","year":"1982","unstructured":"Black KA, Zilko PJ, Dawkins RL, Armstrong BK, Mastaglia GL (1982) Cancer in connective tissue disease. Arthritis Rheum 25:1130\u20131133","journal-title":"Arthritis Rheum"},{"key":"9151_CR21","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/art.1780170407","volume":"17","author":"JJ Canoso","year":"1974","unstructured":"Canoso JJ, Cohen AS (1974) Malignancy in a series of 70 patients with systemic lupus erythematosus. Arthritis Rheum 17:383\u2013390","journal-title":"Arthritis Rheum"},{"key":"9151_CR22","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S0140-6736(78)92645-4","volume":"2","author":"JA Green","year":"1978","unstructured":"Green JA, Dawson AA, Walker W (1978) Systemic lupus erythematosus and lymphoma. Lancet 2:753\u2013756","journal-title":"Lancet"},{"key":"9151_CR23","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1002\/art.1780390625","volume":"39","author":"M Abu-Shakra","year":"1996","unstructured":"Abu-Shakra M, Gladman DD, Urowitz MB (1996) Malignancy in systemic lupus erythematosus. Arthritis Rheum 39:1050\u20131054","journal-title":"Arthritis Rheum"},{"key":"9151_CR24","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1191\/096120301678646128","volume":"10","author":"J Cibere","year":"2001","unstructured":"Cibere J, Sibley J, Haga M (2001) Systemic lupus erythematosus and the risk of malignancy. Lupus 10:394\u2013400","journal-title":"Lupus"},{"key":"9151_CR25","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1191\/096120301678416079","volume":"10","author":"O Nived","year":"2001","unstructured":"Nived O, Bengtsson A, Jonsen A, Sturfelt G, Olsson H (2001) Malignancies during follow-up in an epidemiologically defined systemic lupus erythematosus inception cohort in southern Sweden. Lupus 10:500\u2013504","journal-title":"Lupus"},{"key":"9151_CR26","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1093\/rheumatology\/39.10.1147","volume":"39","author":"SM Sultan","year":"2000","unstructured":"Sultan SM, Ioannou Y, Isenberg DA (2000) Is there an association of malignancy with systemic lupus erythematosus? An analysis of 276 patients under long-term review. Rheumatology (Oxford) 39:1147\u20131152","journal-title":"Rheumatology (Oxford)"},{"key":"9151_CR27","unstructured":"Services USDoHaH (2000) ICD-9-CM: international classification of diseases, 9th Revision, Clinical modification, 6th edition, Washington DC"},{"key":"9151_CR28","unstructured":"Cancer Reporting in California (1997) Standards for automated reporting. California cancer reporting system standards, vol II. California Department of Health Services, Cancer Surveillance Section, Sacramento, CA, December 1997"},{"key":"9151_CR29","unstructured":"Cancer Reporting in California (1997) Data standards for regional registries and California Cancer Registry. California cancer reporting system standards, vol III. California Department of Health Services, Cancer Surveillance Section, Sacramento, CA, December 1997"},{"key":"9151_CR30","unstructured":"Cancer Reporting in California (1998) Reporting procedures for physicians. California cancer reporting system standards, vol IV. California Department of Health Services, Cancer Surveillance Section, Sacramento, CA, January 1998"},{"key":"9151_CR31","unstructured":"Cancer Reporting in California (1997) Abstracting and coding procedures for hospitals. California cancer reporting system standards, vol I. California Department of Health Services, Cancer Surveillance Section, Sacramento, CA, June 1997"},{"key":"9151_CR32","volume-title":"Cancer in North America, 1993\u20131997. Volume I: incidence","author":"VW Chen","year":"2000","unstructured":"Chen VW, Howe HL, Wu XC (2000) Cancer in North America, 1993\u20131997. Volume I: incidence. North American Association of Central Cancer Registries, Springfield"},{"key":"9151_CR33","first-page":"59","volume":"11","author":"JE Seiffert","year":"1990","unstructured":"Seiffert JE, Price WT, Gordon B (1990) The California tumor registry: a state-of-the-art model for a regionalized, automated, population-based registry. Top Health Rec Manage 11:59\u201373","journal-title":"Top Health Rec Manage"},{"key":"9151_CR34","volume-title":"Data reengineering environment software","author":"Integrity Program","year":"1999","unstructured":"Integrity Program (1999) Data reengineering environment software. Vality Technology Inc., Boston"},{"key":"9151_CR35","unstructured":"Allen M (2001) Validation of OSHPD and CCR insurance status. California Association of Central Cancer Registries Technical Conference, Riverside, CA"},{"key":"9151_CR36","volume-title":"International classification of diseases for oncology","author":"A Fritz","year":"2000","unstructured":"Fritz A, Percy C, Jack A et\u00a0al (2000) International classification of diseases for oncology, 3rd edn. World Health Organization, Geneva","edition":"3"},{"key":"9151_CR37","volume-title":"Statistical methods in cancer research, Volume II: the design and analysis of cohort studies","author":"NE Breslow","year":"1987","unstructured":"Breslow NE, Day NE (1987) Statistical methods in cancer research, Volume II: the design and analysis of cohort studies. International Agency for Research on Cancer, Lyon"},{"key":"9151_CR38","first-page":"2551","volume":"29","author":"S Bernatsky","year":"2002","unstructured":"Bernatsky S, Boivin JF, Joseph L et\u00a0al (2002) Prevalence of factors influencing cancer risk in women with lupus: social habits, reproductive issues, and obesity. J Rheumatol 29:2551\u20132554","journal-title":"J Rheumatol"},{"key":"9151_CR39","first-page":"435","volume":"16","author":"IN Bruce","year":"1998","unstructured":"Bruce IN, Gladman DD, Urowitz MB (1998) Detection and modification of risk factors for coronary artery disease in patients with systemic lupus erythematosus: a quality improvement study. Clin Exp Rheumatol 16:435\u2013440","journal-title":"Clin Exp Rheumatol"},{"key":"9151_CR40","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1136\/ard.52.10.720","volume":"52","author":"T McAlindon","year":"1993","unstructured":"McAlindon T, Giannotta L, Taub N, D\u2019Cruz D, Hughes G (1993) Environmental factors predicting nephritis in systemic lupus erythematosus. Ann Rheum Dis 52:720\u2013724","journal-title":"Ann Rheum Dis"},{"key":"9151_CR41","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/0002-9343(92)90578-Y","volume":"93","author":"M Petri","year":"1992","unstructured":"Petri M, Perez-Gutthann S, Spence D, Hochberg MC (1992) Risk factors for coronary artery disease in patients with systemic lupus erythematosus. Am J Med 93:513\u2013519","journal-title":"Am J Med"},{"key":"9151_CR42","first-page":"2363","volume":"26","author":"P Rahman","year":"1999","unstructured":"Rahman P, Urowitz MB, Gladman DD, Bruce IN, Genest J Jr (1999) Contribution of traditional risk factors to coronary artery disease in patients with systemic lupus erythematosus. J Rheumatol 26:2363\u20132368","journal-title":"J Rheumatol"},{"key":"9151_CR43","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1097\/00000441-200605000-00003","volume":"331","author":"MM Ahmed","year":"2006","unstructured":"Ahmed MM, Berney SM, Wolf RE et\u00a0al (2006) Prevalence of active hepatitis C virus infection in patients with systemic lupus erythematosus. Am J Med Sci 331:252\u2013256","journal-title":"Am J Med Sci"},{"key":"9151_CR44","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/S0248-8663(99)83029-X","volume":"20","author":"S Berthier","year":"1999","unstructured":"Berthier S, Mougin C, Vercherin P et\u00a0al (1999) Does a particular risk associated with papillomavirus infections exist in women with lupus? Rev Med Interne 20:128\u2013132","journal-title":"Rev Med Interne"},{"key":"9151_CR45","doi-asserted-by":"crossref","first-page":"3619","DOI":"10.1002\/art.20616","volume":"50","author":"LS Tam","year":"2004","unstructured":"Tam LS, Chan AY, Chan PK, Chang AR, Li EK (2004) Increased prevalence of squamous intraepithelial lesions in systemic lupus erythematosus: association with human papillomavirus infection. Arthritis Rheum 50:3619\u20133625","journal-title":"Arthritis Rheum"},{"key":"9151_CR46","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/S0190-9622(85)80407-2","volume":"13","author":"RH Thomas","year":"1985","unstructured":"Thomas RH, Ridley CM, Black MM (1985) Lichen sclerosus et atrophicus associated with systemic lupus erythematosus. J Am Acad Dermatol 13:832\u2013833","journal-title":"J Am Acad Dermatol"},{"key":"9151_CR47","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1002\/art.1780311212","volume":"31","author":"RB Gibbons","year":"1988","unstructured":"Gibbons RB, Westerman E (1988) Acute nonlymphocytic leukemia following short-term, intermittent, intravenous cyclophosphamide treatment of lupus nephritis. Arthritis Rheum 31:1552\u20131554","journal-title":"Arthritis Rheum"},{"key":"9151_CR48","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1159\/000205024","volume":"84","author":"M Lishner","year":"1990","unstructured":"Lishner M, Hawker G, Amato D (1990) Chronic lymphocytic leukemia in a patient with systemic lupus erythematosus. Acta Haematol 84:38\u201339","journal-title":"Acta Haematol"},{"key":"9151_CR49","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1093\/ajcp\/106.5.676","volume":"106","author":"NS Rosenthal","year":"1996","unstructured":"Rosenthal NS, Farhi DC (1996) Myelodysplastic syndromes and acute myeloid leukemia in connective tissue disease after single-agent chemotherapy. Am J Clin Pathol 106:676\u2013679","journal-title":"Am J Clin Pathol"},{"key":"9151_CR50","first-page":"1625","volume":"19","author":"S Vasquez","year":"1992","unstructured":"Vasquez S, Kavanaugh AF, Schneider NR, Wacholtz MC, Lipsky PE (1992) Acute nonlymphocytic leukemia after treatment of systemic lupus erythematosus with immunosuppressive agents. J Rheumatol 19:1625\u20131627","journal-title":"J Rheumatol"},{"key":"9151_CR51","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1136\/bmj.284.6323.1160","volume":"284","author":"RW Elliott","year":"1982","unstructured":"Elliott RW, Essenhigh DM, Morley AR (1982) Cyclophosphamide treatment of systemic lupus erythematosus: risk of bladder cancer exceeds benefit. Br Med J (Clin Res Ed) 284:1160\u20131161","journal-title":"Br Med J (Clin Res Ed)"},{"key":"9151_CR52","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1159\/000186790","volume":"60","author":"A Ortiz","year":"1992","unstructured":"Ortiz A, Gonzalez-Parra E, Alvarez-Costa G, Egido J (1992) Bladder cancer after cyclophosphamide therapy for lupus nephritis. Nephron 60:378\u2013379","journal-title":"Nephron"},{"key":"9151_CR53","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0022-5347(17)39886-5","volume":"143","author":"JB Thrasher","year":"1990","unstructured":"Thrasher JB, Miller GJ, Wettlaufer JN (1990) Bladder leiomyosarcoma following cyclophosphamide therapy for lupus nephritis. J Urol 143:119\u2013121","journal-title":"J Urol"},{"key":"9151_CR54","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1002\/art.21458","volume":"53","author":"S Bernatsky","year":"2005","unstructured":"Bernatsky S, Boivin JF, Joseph L et\u00a0al (2005) Race\/ethnicity and cancer occurrence in systemic lupus erythematosus. Arthritis Rheum 53:781\u2013784","journal-title":"Arthritis Rheum"},{"issue":"9","key":"9151_CR55","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1136\/ard.2005.046896","volume":"65","author":"GS Alarcon","year":"2006","unstructured":"Alarcon GS, Calvo-Alen J, McGwin G et\u00a0al (2006) Systemic lupus erythematosus in a multiethnic cohort: LUMINA XXXV. Predictive factors of high disease activity over time. Ann Rheum Dis 65(9):1168\u20131174","journal-title":"Ann Rheum Dis"},{"key":"9151_CR56","first-page":"45","volume":"33","author":"SR Bernatsky","year":"2006","unstructured":"Bernatsky SR, Cooper GS, Mill C, Ramsey-Goldman R, Clarke AE, Pineau CA (2006) Cancer screening in patients with systemic lupus erythematosus. J Rheumatol 33:45\u201349","journal-title":"J Rheumatol"},{"key":"9151_CR57","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1002\/art.1780400908","volume":"40","author":"JN Katz","year":"1997","unstructured":"Katz JN, Barrett J, Liang MH et\u00a0al (1997) Sensitivity and positive predictive value of Medicare Part B physician claims for rheumatologic diagnoses and procedures. Arthritis Rheum 40:1594\u20131600","journal-title":"Arthritis Rheum"},{"issue":"12","key":"9151_CR58","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1136\/ard.2006.067108","volume":"66","author":"B L\u00f6fstr\u00f6m","year":"2007","unstructured":"L\u00f6fstr\u00f6m B, Backlin C, Sundstr\u00f6m C, Ekbom A, Lundberg IE (2007) A closer look at non-Hodgkin\u2019s lymphoma cases in a national Swedish systemic lupus erythematosus cohort: a nested case-control study. Ann Rheum Dis 66(12):1627\u20131632","journal-title":"Ann Rheum Dis"},{"key":"9151_CR59","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1002\/art.1780400928","volume":"40","author":"MC Hochberg","year":"1997","unstructured":"Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40:1725","journal-title":"Arthritis Rheum"}],"container-title":["Cancer Causes & Control"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-008-9151-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10552-008-9151-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-008-9151-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T17:05:53Z","timestamp":1559235953000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10552-008-9151-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4,2]]},"references-count":59,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2008,10]]}},"alternative-id":["9151"],"URL":"https:\/\/doi.org\/10.1007\/s10552-008-9151-8","relation":{},"ISSN":["0957-5243","1573-7225"],"issn-type":[{"value":"0957-5243","type":"print"},{"value":"1573-7225","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,4,2]]}}}